Natural Molecular launch a positive for Luminex, says Leerink

Leerink views the launch of Natural Molecular Testing's Personalized Medicine Panel using Luminex (LMNX) technology as a material positive for Luminex and negative for GenMark (GNMK). Leerink says GenMark receives 60% of its revenue from Natural Molecular and that it expects some of this revenue to now transfer to Luminex.

View Comments (0)